Acris Antibodies Logo

Antibodies and related products for scientific research: primary antibodies: 80.030, secondary ab: 1.977, proteins: 20.631, kits: 265, other products: 2.216

No staining picture available ...

 

Zoom Out
Zoom In

BA443  Matrix Metalloproteinase-9 (MMP-9) (pro) antigen


see all 31 Matrix Metalloproteinase-9 products
5 µg / US$ 455
NOVUS BIOLOGICALS
PO Box 802 Littleton, CO 80160, USA
E-Mail: novus@novus-biologicals.com
Homepage: http://www.novus-biologicals.com

Quick Overview

Human Matrix Metalloproteinase-9 (MMP-9) (pro)

Synonyms

MMP9, CLG4B, Gelatinase B, GELB,

Product Description

Human Matrix Metalloproteinase-9 (MMP-9) (pro)

Properties

SpeciesHuman
Purity>98%
SourceCarcinoma
Catalog NumberBA443
Quantity5 µg
PriceUS$ 455
DeliveryWorldwide
ManufacturerAcris Antibodies GmbH
Datasheetview PDF-Download
BA443.pdf

Datasheet Extract

Concentration0.2 mg/ml
SourceHuman blood
Format
State: Liquid
Purity: SDS PAGE: >95%
This preparation is free from gelatinase B dimers and from complexes of gelatinase B with TIMP-1 or lipocalin.
BufferSystem: TRIS buffered saline containing 0.05% Sodium Azide and 0.05% Brij-35
ApplicationsELISA.
Functional Assays.
Description350-450 mU/mg after trypsin activation. 1 U is defined as the the amount needed to hydrolyze 1 µmol of the peptide, Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg per minute.
Molecular weight: 92 kDa.
Add. InformationA singlet of 92 kDa which upon activation exhibits a relatively stable band at 84 kDa. Lower bands are observed
with increased activation.
StorageStore the protein undiluted at -20°C for 3 weeks or (in aliquots) at -70°C for longer.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
CautionSource material supplied to your facility has been tested for the detection of HIV antibody, Hepatitis B surface antigen, antibody to Hepatitis C, HIV 1 antigen(s), antibody to HTLV - I/II, and syphilis with FDA approved test kits. All units were found to be non-reactive/negative for these tests. Nevertheless, all products from human sources should be handled as potentially infectious.